Table 1.
Patient characteristics (n = 493).
| Characteristic | Patients, n (%) |
|---|---|
| Age | |
| 70–74 | 169 (34%) |
| 75–79 | 152 (31%) |
| ≥80 | 172 (35%) |
| Sex | |
| Male | 310 (63%) |
| Female | 183 (37%) |
| Tumor site | |
| Gastrointestinal | 256 (52) |
| Genitourinary | 64 (13) |
| Lung | 59 (12) |
| Breast | 30 (6) |
| Gynecologic | 15 (3) |
| Other | 69 (14) |
| Metastatic status | |
| M0 | 209 (42%) |
| M1 | 284 (58%) |
| ECOG PS | |
| 0 | 126 (25%) |
| 1 | 304 (62%) |
| 2 | 63 (13%) |
| IADL | |
| 8 | 217 (44%) |
| ≤7 | 276 (56%) |
| ADL | |
| 6 | 387 (79%) |
| ≤5 | 106 (21%) |
| Number of falls in the past 6 months | |
| None | 409 (83%) |
| ≥1 | 85 (17%) |
| Charlson comorbidity score | |
| 0 | 166 (34%) |
| 1 | 142 (29%) |
| ≥2 | 185 (37%) |
| VES-13 | |
| 0–2 | 171 (35%) |
| ≥3 | 322 (65%) |
| Chemotherapy | |
| Standard therapy | 215 (44%) |
| Reduced therapy or monotherapy | 278 (56%) |
| MAX2 index | |
| 0 | 151 (31%) |
| 1 | 292 (59%) |
| 2 | 50 (10%) |
Abbreviations: ECOG PS: Eastern Cooperative Oncology Group performance status. ADL: activity of daily living, IADL: instrumental activity of daily living, VES-13: Vulnerable Elders Survey-13.